Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C22H26O6 |
Molecular Weight | 386.4382 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 4 / 4 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[H][C@]12CO[C@H](C3=CC=C(OC)C(OC)=C3)[C@@]1([H])CO[C@H]2C4=CC=C(OC)C(OC)=C4
InChI
InChIKey=PEUUVVGQIVMSAW-WWLNLUSPSA-N
InChI=1S/C22H26O6/c1-23-17-7-5-13(9-19(17)25-3)21-15-11-28-22(16(15)12-27-21)14-6-8-18(24-2)20(10-14)26-4/h5-10,15-16,21-22H,11-12H2,1-4H3/t15-,16-,21-,22+/m0/s1
Molecular Formula | C22H26O6 |
Molecular Weight | 386.4382 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 4 / 4 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Epipinoresinol is an important component of the medicinal herb Eucommia ulmoides, which has a substantial reputation as an effective antihypertensive remedy. Epipinoresinol (EPR) belongs to the group
of furofuran-type lignans consisting of two phenylpropane units. (+)-epipinoresinol exhibited antiplatelet aggregation activity. It also exhibited inhibitory effects on nitric oxide production. Epipinoresinol possess antiproliferative activity.
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: GO:0006809 Sources: https://www.ncbi.nlm.nih.gov/pubmed/24963714 |
39.5 µM [IC50] | ||
Target ID: CHEMBL3979 Sources: https://www.ncbi.nlm.nih.gov/pubmed/22381047 |
49.5 µM [EC50] | ||
Target ID: CHEMBL235 Sources: https://www.ncbi.nlm.nih.gov/pubmed/22381047 |
58.6 µM [EC50] | ||
Target ID: CHEMBL3559683 Sources: https://www.ncbi.nlm.nih.gov/pubmed/22381047 |
10.3 µM [EC50] | ||
Target ID: GO:0070527 Sources: https://www.ncbi.nlm.nih.gov/pubmed/25555357 |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Primary | Unknown Approved UseUnknown |
|||
Primary | Unknown Approved UseUnknown |
PubMed
Title | Date | PubMed |
---|---|---|
Phenolic constituents from Parakmeria yunnanensis and their anti-HIV-1 activity. | 2013 Oct |
|
Lignans and aromatic glycosides from Piper wallichii and their antithrombotic activities. | 2015 Mar 13 |
|
Optimized conversion of antiproliferative lignans pinoresinol and epipinoresinol: Their simultaneous isolation and identification by centrifugal partition chromatography and high performance liquid chromatography. | 2017 May 1 |
Patents
Sample Use Guides
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/24963714
Epipinoresinol inhibited LPS-induced NO production in macrophage RAW 264.7 cells with IC50 value of 39.5 uM.
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 09:23:51 GMT 2023
by
admin
on
Sat Dec 16 09:23:51 GMT 2023
|
Record UNII |
NFK65X655A
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
7000209
Created by
admin on Sat Dec 16 09:23:51 GMT 2023 , Edited by admin on Sat Dec 16 09:23:51 GMT 2023
|
PRIMARY | |||
|
NFK65X655A
Created by
admin on Sat Dec 16 09:23:51 GMT 2023 , Edited by admin on Sat Dec 16 09:23:51 GMT 2023
|
PRIMARY | |||
|
60102-89-8
Created by
admin on Sat Dec 16 09:23:51 GMT 2023 , Edited by admin on Sat Dec 16 09:23:51 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> ACTIVE CONSTITUENT ALWAYS PRESENT |
0.91 uM IC50 for PAF binding in rabbit blood.
|